Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News ESC 2025

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

Caitlin E. Cox

August 30, 2025

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

News Daily News

Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM

Todd Neale

September 15, 2022

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Yael L. Maxwell

July 11, 2019

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

Todd Neale

May 14, 2019

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Daily News

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

L.A. McKeown

October 23, 2012

Advertisement

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM

Women Less Likely Than Men to Experience SCD During Sports

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Cancer Survivors With Heart Failure Respond Well to CRT

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Survival After Septal Ablation for HOCM Similar to General Population

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content